| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 03/17/2004 | CN1482121A Process for preparing N-formyl morpholine |
| 03/16/2004 | US6706923 Perfluoroalkyl-substituted amines, acids, amino acids and thioether acids |
| 03/16/2004 | US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/16/2004 | US6706745 Biphenylamidine derivatives |
| 03/16/2004 | US6706742 Alpha-amino-acid compounds |
| 03/16/2004 | US6706716 Compounds specific for the human α1d adrenergic receptor and uses thereof |
| 03/16/2004 | US6706715 Reversible inhibitors of the blood clotting enzyme factor viia |
| 03/16/2004 | US6706712 Cyclic derivatives as modulators of chemokine receptor activity |
| 03/16/2004 | US6706710 Form of (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 03/11/2004 | WO2004021500A1 Nonaqueous electrolyte and nonaqueous-electrolyte secondary battery |
| 03/11/2004 | WO2004020422A1 1, 4- substituted piperidine derivatives and use thereof as base-inhibitors in treatment of alzheimer's disease |
| 03/11/2004 | WO2004020401A1 Synthesis of sulfonamide derivatives |
| 03/11/2004 | WO2004019946A1 Inhibitors for excessive accumulation of sodium ion in cells |
| 03/11/2004 | WO2004019926A1 Preventive and/or therapeutic agent for heart failure |
| 03/11/2004 | WO2004009578A3 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them |
| 03/11/2004 | WO2004000789A9 Amide linker peroxisome proliferator activated receptor modulators |
| 03/11/2004 | WO2003078420A3 Process for making chiral 1,4-disubstituted piperazines |
| 03/11/2004 | WO2003006444A3 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
| 03/11/2004 | WO2003002524A3 Urea derivatives with antiproteolytic activity |
| 03/11/2004 | US20040049083 Arylpiperazines having activity at the serotonin 1A receptor |
| 03/11/2004 | US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease |
| 03/11/2004 | US20040049033 Acylated aminothiol compound |
| 03/11/2004 | US20040048897 Il-8 receptor antagonists |
| 03/11/2004 | US20040048891 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
| 03/11/2004 | US20040048875 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 03/11/2004 | US20040048872 Sedatives, anticonvulsants, hypnotics and general anesthetics. |
| 03/11/2004 | US20040048856 Monoamine reuptake inhibitors for treatment of CNS disorders |
| 03/11/2004 | US20040048851 Amidinophenylalanine derivatives as thrombin inhibitors |
| 03/11/2004 | DE10238865A1 New carboxamides are melanin-concentrating hormone receptor antagonists, useful for treating e.g. metabolic diseases, diabetes, eating disorders, cardiovascular disease, emotional disorders, reproductive and memory disorders |
| 03/11/2004 | CA2497109A1 Nonaqueous electrolyte and nonaqueous electrolyte secondary battery |
| 03/10/2004 | EP1395567A1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395561A1 Carbamate and oxamide compounds as inhibitors of cytokine production |
| 03/10/2004 | EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 03/10/2004 | EP1395548A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
| 03/10/2004 | EP1395265A2 Combretastatin a-3 prodrug |
| 03/10/2004 | EP1395256A2 Prodrugs via acylation with cinnamate |
| 03/10/2004 | EP1303249B1 Antimycotic nail varnish composition |
| 03/10/2004 | CN1481376A Oxybenzamides derivatives as factor xa inhibitors |
| 03/10/2004 | CN1481358A Carboxylic acid amide derivatives and their use in treatment of thromboembolic diseases and tumours |
| 03/10/2004 | CN1481238A Aniline derivatives or salts thereof and cytokine prodn inhibitors contg. same |
| 03/10/2004 | CN1480438A Stable ethene in hibitory compound and its prepn method |
| 03/10/2004 | CN1141301C Prepn of acetyl morphine |
| 03/09/2004 | US6703507 Nonaqueous liquid comprising the ammonium salt of a sulfonated or carboxylated phosphite ligand; use as a media for chemical reactions, including those using transition metal catalysts |
| 03/09/2004 | US6703403 Method for improving pharmacokinetics |
| 03/09/2004 | US6703368 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 03/04/2004 | WO2004018461A2 Antibacterial benzoic acid derivatives |
| 03/04/2004 | WO2004018442A1 Crystalline and amorphous forms of (s) -repaglinide and the processes for preparation thereof |
| 03/04/2004 | WO2004018436A2 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 03/04/2004 | WO2004018414A2 Antibacterial agents |
| 03/04/2004 | WO2003075907A3 Small molecule entry inhibitors |
| 03/04/2004 | WO2002098856A3 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists |
| 03/04/2004 | WO2002038540A9 Activity-dependent cysteine protease profiling reagent |
| 03/04/2004 | US20040044250 Transition-metal-catalyzed carbon-nitrogen bond-forming methods using carbene ligands |
| 03/04/2004 | US20040044202 Functionalized monomers for synthesis of rubbery polymers |
| 03/04/2004 | US20040044081 Hypotensive agents; cardiovascular disorders; anticholesterol agents; antiarrhythmia agents |
| 03/04/2004 | US20040044061 Analgesics; side effect reduction |
| 03/04/2004 | US20040044049 Compounds for inhibiting insulin secretion and methods related thereto |
| 03/04/2004 | US20040044047 Alpha and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 03/04/2004 | US20040044037 Sleep disorders; antidepressants; analgesics; central nervous system disorders |
| 03/04/2004 | US20040044009 Drug abuse; cental nervous system disorders; cognition activators |
| 03/04/2004 | US20040044008 Dietetics; antilipemic agents; non-insulin dependent diabetes; cardiovascular disorders |
| 03/04/2004 | US20040044004 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| 03/03/2004 | EP1392779A1 Fluorinated-photoinitiators in dual cure resins |
| 03/03/2004 | EP1392667A1 Method for the production of biperidin |
| 03/03/2004 | EP1392660A1 Substituted benzoylcyclohexenones and their use as herbicidal agents |
| 03/03/2004 | EP1392644A1 Cinnamide derivatives as kcnq potassium channel modulators |
| 03/03/2004 | EP1392639A1 Pyruvate derivatives |
| 03/03/2004 | EP1392637A2 Modulators of peroxisome proliferator activated receptors |
| 03/03/2004 | EP1392315A1 Methods of treating alzheimer's disease |
| 03/03/2004 | EP1392280A2 Arylsulfonamide ethers, and methods of use thereof |
| 03/03/2004 | EP1124797B1 N-arylsulfonyl amino acid omega amides |
| 03/03/2004 | EP0938317B1 Compositions for reducing respiratory depression |
| 03/03/2004 | CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor |
| 03/03/2004 | CN1140459C Method of removing N-nitrosomorpholine and its application |
| 03/02/2004 | US6700007 Method for preparing alkoxyamines from nitroxides |
| 03/02/2004 | US6699990 Colorfastness; waterproofing; oxidative color hair dyes |
| 03/02/2004 | US6699898 Method of treating coronary artery disease or other cetp-mediated disorders in a subject by administering a therapeutically effective amount of a compound of one of claims |
| 03/02/2004 | US6699893 Glucocorticoid receptor modulators |
| 03/02/2004 | US6699891 Npyy5 antagonists |
| 03/02/2004 | US6699867 4-(4-Methyl-piperazin-1-ylmethyl)-4,5-dihydrothiazol-2-ylamine |
| 03/02/2004 | US6699467 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
| 02/26/2004 | WO2004016576A1 Fused benzene derivative and use |
| 02/26/2004 | WO2003097575A3 Amino-functional chalcones |
| 02/26/2004 | WO2003097574A3 Aminoalkoxy-functional chalcones |
| 02/26/2004 | WO2003057144A3 Change inhibitors of dipeptidyl peptidase iv |
| 02/26/2004 | WO2002098869A3 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 02/26/2004 | WO2002096869A3 Piperazine mono(dithio)carbamate ester compounds and analogs thereof |
| 02/26/2004 | WO2002083067A9 Prodrugs via acylation with cinnamate |
| 02/26/2004 | WO2002057211A8 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 02/26/2004 | US20040039203 Reacting an aminoguanidine derivative with an aldehyde to form an intermediate, reacting intermediate with an aromatic acid derivative in presence of alkali metal alcoholate |
| 02/26/2004 | US20040039061 Suppress expression and induction of inflammatory cytokines, cell adhesion molecule gene and virus and suppressors for nuclear factor kappa beta (nf-kb) |
| 02/26/2004 | US20040039053 Administering to a patient a (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives or salt, free of its (+) stereoisomer to treat the type II diabetes, gout, insulin resistance and atherosclerosis |
| 02/26/2004 | US20040039020 Novel pharmaceutical formulation suitable for nebulisation |
| 02/26/2004 | US20040038989 (S)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol cyclic acetals, useful as intermediates for the preparation of levodropropizine |
| 02/26/2004 | US20040038983 3-aza- and 1,4-diaza-bicyclo[4.3.0]nonanes, and methods of use thereof |
| 02/26/2004 | US20040038941 Compounds for the treatment of inflammatory disorders |
| 02/26/2004 | US20040038858 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 02/26/2004 | US20040037022 Aminoalcohol derivatives |
| 02/26/2004 | CA2495383A1 Fused benzene derivative and use |
| 02/25/2004 | EP1391199A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |